Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fibrinopeptide a

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with fibrinopeptide a in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(fibrinopeptide a)
Trials
(fibrinopeptide a)
Recent Studies (post-2010) (fibrinopeptide a)
9,1561875521,33610450

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Addonizio, VP; Berkowitz, HD; Cottrell, ED; Ellison, N; Fisher, CA; Kappa, JR; Sobel, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fibrinopeptide a

ArticleYear
Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374).
    Journal of vascular surgery, 1987, Volume: 5, Issue:5

    Topics: Aged; Aspirin; beta-Thromboglobulin; Cardiovascular Agents; Carotid Arteries; Drug Evaluation; Endarterectomy; Epoprostenol; Fibrinopeptide A; Heparin; Humans; Iloprost; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Platelet Factor 4; Preoperative Care; Thrombosis

1987